Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Randomized Study of Sulindac in Oral Premalignant Lesions

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Amrita Institute of Sciences, AIMS, Cochin, India
Weill Medical College of Cornell University
Regional Cancer Center(RCC), Trivandrum, India
Narayana Hrudayalaya Hospitals
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center.
ClinicalTrials.gov Identifier:
NCT00299195
First received: March 2, 2006
Last updated: February 16, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)